Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations

被引：0
|
作者：
Mueller, Martin C. [1 ]
Cortes, Jorge [2 ]
Kim, Dong-Wook [3 ]
Druker, Brian J. [4 ]
Erben, Philipp [1 ]
Pasquini, Ricardo [5 ]
Hughes, Timothy P. [6 ]
Matloub, Yousif [7 ]
Ploughman, Lynn [7 ]
Hochhaus, Andreas [1 ]
机构：
[1] Univ Heidelberg, Med Fak Mannheim, D-6800 Mannheim, Germany
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] St Marys Hosp, Div Hematol, Seoul, South Korea
[4] Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97201 USA
[5] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil
[6] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[7] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [41] Ponatinib As Initial Therapy For Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP)
    Cortes, Jorge E.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval
    Quintas-Cardama, Alfonso
    Ravandi, Farhad
    Gachimova, Evguenia
    Estrov, Zeev
    Jabbour, Elias
    O'Brien, Susan
    Kantarjian, Hagop
    BLOOD, 2013, 122 (21)
  • [42] MOLECULAR RESPONSE KINETICS AND BCR-ABL REDUCTIONS IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) RECEIVING DASATINIB VS IMATINIB: DASISION 3-YEAR FOLLOW-UP
    Hochhaus, A.
    Boque, C.
    Bradley Garelik, M.
    Manos, G.
    Steegmann, J. L.
    HAEMATOLOGICA, 2012, 97 : 76 - 76
  • [43] BCR-ABL mutations in chronic myeloid leukemia - Not only detection
    Polakova, Katerina Machova
    Zmekova, Vaclava
    Rulcova, Jana
    Klamova, Hana
    Zemanova, Zuzana
    Moravcova, Jana
    LEUKEMIA & LYMPHOMA, 2008, 49 (08) : 1620 - 1622
  • [44] RAPID INITIAL DECLINE IN BCR-ABL LEVELS IS ASSOCIATED WITH SUPERIOR RESPONSES IN IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE (CML-CP) TREATED WITH NILOTINIB
    Stein, A.
    Shou, Y.
    Bottino, D.
    Chia, Y. L.
    Woodman, R.
    Martinelli, G.
    Hughes, T.
    Mueller, M.
    Beppu, L.
    Gottardi, E.
    Branford, S.
    Soverini, S.
    Goh, H.
    Hochhaus, A.
    Kim, D.
    Saglio, G.
    Radich, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 56 - 56
  • [45] The Incidence of BCR-ABL Mutations and Their Impact on Outcome in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib or Imatinib in ENESTnd: 36-Month Follow-up
    Hughes, Timothy P.
    Kim, Dong-Wook
    Etienne, Gabriel
    De Souza, Carmino
    Kurokawa, Mineo
    Kalaycio, Matt
    Saglio, Giuseppe
    Larson, Richard A.
    Kantarjian, Hagop M.
    Hoenekopp, Albert
    Shou, Yaping
    Yu, Richard
    Blakesley, Rick E.
    Rosti, Gianantonio
    Hochhaus, Andreas
    BLOOD, 2011, 118 (21) : 1184 - 1185
  • [46] Dynamics of BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Obstfelder, E.
    Rinke, J.
    Schmidt, M.
    Schaefer, V.
    Waldau, A.
    Winkelmann, N.
    Hochhaus, A.
    Ernst, T.
    Oncology Research and Treatment, 2015, 38 : 188 - 189
  • [47] Nilotinib or Dasatinib Front-Line Therapy in Patients (Pts) With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP) With Pre-existing Liver and/or Renal dysfunction
    Sasaki, Koji
    Kantarjian, Hagop
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Pierce, Sherry
    Borthakur, Gautam
    Kadia, Tapan
    Pemmaraju, Naveen
    Ferrajoli, Alessandra
    O'Brien, Susan
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S138 - S139
  • [48] Imatinib dose escalation is effective in patients with chronic myeloid leukemia in chronic phase (CML-CP)
    Kantarjian, Hagop M.
    Druker, Brian J.
    Guilhot, Francois
    Cortes, Jorge
    O'Brien, Stephen G.
    Krahnke, Tillmann
    Larson, Richard A.
    BLOOD, 2007, 110 (11) : 317A - 317A
  • [49] Therapy with Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)
    Naqvi, Kiran
    Cortes, Jorge
    Skinner, Jeffrey
    Jabbour, Elias
    Pemmaraju, Naveen
    Borthakur, Gautam
    Estrov, Zeev
    Bose, Prithviraj
    Thompson, Philip
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S317 - S317
  • [50] Dasatinib as initial therapy for patients with chronic myeloid leukemia (CML) in early chronic phase (CP)
    Pemmaraju, Naveen
    Kantarjian, Hagop
    O'Brien, Susan
    Luthra, Raja
    Jabbour, Elias
    Quintas-Cardama, Aflonso
    Borthakur, Gautam
    Ravandi, Farhad
    Burton, Elizabeth
    Walker, Brenda
    Cortes, Jorge
    CANCER RESEARCH, 2011, 71
12345